LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector

Thursday, Laboratory Corp A reported second-quarter 2024 adjusted EPS of $3.94, up from$3.42 a year ago, beating the consensus of $3.78. Sales increased 6.2$3.22 billion, beating the consensus of $3.19 billion. The increase was due to organic revenue of 3.8%, acquisitions, and net of divestitures of 2.5%, partially offset by foreign currency translation of (0.1%). The 3.8% increase in organic revenue was driven by a 4.5% increase in the company's organic Base Business, partially offset ...